Please provide your email address to receive an email when new articles are posted on . Many adult survivors of childhood cancer are not regularly screened for cardiovascular disease. Primary ...
Experts discuss atherosclerotic cardiovascular disease and aortic stenosis, as well as their burden, highlighting their prevalence, impact on patient health, and the growing need for effective ...
The results of a recent retrospective analysis of electronic health record (EHR) data found that only 0.4% of patients with atherosclerotic cardiovascular disease (ASCVD) were tested for lipoprotein(a ...
Series of studies will focus on genetic drivers of cardiovascular disease, and how data can improve care, especially in underserved communities SAN DIEGO, April 11, 2023 /PRNewswire/ -- Illumina Inc. ...
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Ambry Genetics (“Ambry”) announces the launch of powerful cardiovascular genetic testing panels for inherited cardiomyopathies and arrhythmias. These feature an ...
BARCELONA -- In Denmark, population-based screening for subclinical cardiovascular disease (CVD) did not prevent deaths in men except perhaps those younger than age 70, a randomized trial found. Among ...
Currently available therapies such as niacin and PCSK9 inhibitors such as Repatha (evolocumab) and Praluent (alirocumab) can reduce Lp (a) levels, but their impact is modest. Another challenge in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results